Oppenheimer Initiates Coverage On Passage Bio with Outperform Rating, Announces Price Target of $30
Benzinga Newsdesk 7 months ago
NewsPrice TargetInitiationAnalyst Ratings
Oppenheimer analyst Jay Olson initiates coverage on Passage Bio (NASDAQ:PASG) with a Outperform rating and announces Price Target of $30.
Oppenheimer analyst Jay Olson initiates coverage on Passage Bio (NASDAQ:PASG) with a Outperform rating and announces Price Target of $30.